NCT04461054 is a clinical trial in Colorectal Disorders, sponsored by Leonardo Bustamante-Lopez.

Who is sponsoring NCT04461054?

NCT04461054 is sponsored by Leonardo Bustamante-Lopez.

What condition does NCT04461054 study?

NCT04461054 studies Colorectal Disorders.

Is NCT04461054 still recruiting?

NCT04461054 is currently status unknown. Last updated 8 July 2020.

Last reviewed 2020-07-08 · How we verify

NCT04461054

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Which Type of Laparoscopic Colectomy, Right or Left, Have Better Postoperative Outcomes for the Patients?

Status unknown Last updated 8 July 2020

What this trial tests

trial in Colorectal Disorders in 332 participants. Status unknown.

Timeline

2 January 2020

Primary endpoint
1 September 2020

1 December 2020

Quick facts

Lead sponsor	Leonardo Bustamante-Lopez
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	332
Start date	2 January 2020
Primary completion	1 September 2020
Estimated completion	1 December 2020
Sites	1 location across Brazil

Conditions studied

Colorectal Disorders — all drugs for Colorectal Disorders →

Sponsor

Leonardo Bustamante-Lopez

Who can join

Adults 18 to 80, any sex, with Colorectal Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laparoscopic surgery decreased the morbidity of colorectal surgery. The two most common surgeries for colorectal cancer are right and left colectomy. Objective: To compare perioperative morbidity of the right versus left colectomy for cancer, as well as the quality of laparoscopic oncologic resection of both procedures. Methods: Retrospective analysis of prospectively collected data from patients operated at the University of São Paulo School of Medicine, between 2006 and 2016. Postoperative complications were classified with scale within 30 days after surgery. Grade III or greater was considered serious complication. Quality of oncologic resection was assessed by the average number of lymph nodes harvested and surgical margins.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Colorectal Disorders

Currently open trials in the same condition.

NCT06657924 — Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery · Phase 2 · recruiting
NCT06339671 — Post-operative Complications and Smoking Habits in Colorectal Surgery · recruiting
NCT06430931 — Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery · NA · recruiting
NCT05005117 — Laparoscopic Approach for Emergency Colon Resection · NA · recruiting
NCT06342440 — Early Detection of Advanced Adenomas and Colorectal Cancer · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04461054 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Leonardo Bustamante-Lopez
Last refreshed: 8 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04461054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing